Agendia Pockets $34M in Fourth VC Financing Round | GenomeWeb
NEW YORK (GenomeWeb News) — Agendia yesterday said that it has raised €25 million ($34 million) in a fourth financing round.
Bank-insurer ING becomes a shareholder, though Agendia would not disclose the amount it invested. However, Agendia called it a “powerful and substantial shareholder.”
Also participating in the round were current investors Van Herk Biotech, Gilde Healthcare Partners, and Gobal Life Science Ventures.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.